The CDC 2002 guidelines for the treatment of sexually transmitted diseases: implications for women's health care.

Persons rely on health care providers to make diagnostic and therapeutic decisions based on the most current information. With areas of practice changing rapidly, providers are challenged to keep abreast of new and changing treatment guidelines. The new Centers for Disease Control and Prevention (CDC) 2002 Sexually Transmitted Disease (STD) Treatment Guidelines provide clinical guidance in the appropriate assessment and management of STDs.

Sexually transmitted disease screening by United States obstetricians and gynecologists.

Objective: To assess compliance with practice guidelines and to determine the extent of missed opportunities for sexually transmitted disease (STD) prevention by describing screening practices of a national sample of obstetricians and gynecologists and comparing them to the practices of other specialists.

Methods: Physicians (n = 7300) in five specialties that diagnose 85% of STDs in the United States were surveyed. Obstetrics and gynecology (n = 647) was one of the five specialties.

Caring for the woman with migraine headaches.

About 16% of American women experience migraine headaches. These debilitating headaches cause lost time from family, social activities, and work. Although migraines are thought to be a result of shifting menstrual and perimenopausal hormones, a physiologic connection has not been well established.

Caring for the woman with migraine headaches.

Approximately 16% of American women experience migraine headaches. These debilitating headaches cause lost time from family, social activities, and work. Although migraines are thought to be a result of shifting menstrual and perimenopausal hormones, a physiologic connection has not been well established.

A clinician's guide to Pap smear interpretation.

Cervical cancer is the seventh most common cause of death from cancer in the United States and the most common cause of cancer in women around the world. In the United States, in 1995 alone, there were 15,800 cases of invasive cervical cancer that resulted in 4,800 deaths. The Papanicolaou (Pap) smear screen has helped in the identification of preinvasive disease, and, in fact, the cure rate for cervical disease is greater than 95% with early diagnosis using this test.